Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma

Modern Pathology

Volumn 17, Issue 4, 2004, Pages 449-455

  Farabegoli, Fulvia ^a   Hermsen, Mario A J A ^b   Ceccarelli, Claudio ^a   Santini, Donatella ^a   Weiss, Marianne M ^b   Meijer, Gerrit A ^b   Van Diest, Paul J ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast carcinoma; Chromosome 16q losses; Chromosome 1q gains; Comparative genomic hybridization

Indexed keywords

CYCLIN A; CYCLIN D1; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; STEROID RECEPTOR; DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 16Q; CHROMOSOME 1Q; CHROMOSOME LOSS; CHROMOSOMES AND CHROMOSOMAL PHENOMENA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; ANEUPLOIDY; BREAST TUMOR; CHROMOSOME 1; CHROMOSOME 16; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; GENETICS; IMAGE CYTOMETRY; METABOLISM; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 16; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; RECEPTORS, STEROID; TUMOR MARKERS, BIOLOGICAL;

EID: 4644231791     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800059     Document Type: Article

References (21)

1. Dutrillaux B, Gerbault-Seureau M, Zafrani B. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 1990;49:203-217.
2. Pandis N, Jin Y, Gorunova L, et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 1995;12:173-185.
3. Roylance R, Gorman P, Harris W, et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 1999;59:1433-1436.
4. Bürger H, Otterbach F, Simon R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999;189:521-526.
5. Texeira MR, Pandis N, Heim S. Cytogenetic clues to breast carcinogenesis. Genes Chromosomes Cancer 2002;33:1-16.
6. Tsarouha H, Pandis N, Bardi G, et al. Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet Cytogenet 1999;13:156-161.
7. Bürger H, Mommers E, Littmann R, et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stage of at least two different lines of genetic evolution. J Pathol 2001;194:165-170.
8. WHO. The World Health Organization histologic typing of breast tumours. (2nd edition). Am J Clin Pathol 1982;78:806-816.
9. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
10. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994;10:231-243.
11. Weiss MM, Hermsen MA, Meijer GA, et al. Comparative genomic hybridisation. Mol Pathol 1999;52:243-251.
12. Faccioli S, Chieco P, Gramantieri L, et al. Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver. Mod Pathol 1996;9:120-125.
13. Ceccarelli C, Santini D, Chieco P, et al. Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile. J Clin Pathol 1998;51:818-824.
14. kipi: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-323.
15. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
16. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002;99:12963-12968.
17. Kokalj-Vokac N, Alemeida A, Gerbault-Seureau M, et al. Two-color FISH characterization of i(1q) and der(l;16) in human breast cancer cells. Genes Chromosomes Cancer 1993;7:8-14.
18. Trent J, Yang JM, Emerson J, et al. Clonal chromosome abnormalities in human breast carcinomas. II. Thirty-four cases with metastatic disease. Genes Chromosomes Cancer 1993;4:194-203.
19. Farabegoli F, Ceccarelli C, Santini D, et al. Chromosome 1 aneusomy with Ip36 underrepresentation is related to histologic grade, DNA aneuploidy, high c-erb B-2 and loss of bcl-2 expression in ductal breast carcinoma. Int J Cancer 1996;69:381-385.
20. Tirkkonen M, Tanner M, Karhu R, et al. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998:3:177-184.
21. Nishizaki T, Chew K, Chu L, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997;74:513-517.